Redmile Group, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Silence Therapeutics plc Ordinary Shares, nominal value GBP 0.05 per share

Filing Manager: Redmile Group, LLC
Reporting Manager: Redmile Group, LLC
Security: Silence Therapeutics plc Ordinary Shares, nominal value GBP 0.05 per share
Shares outstanding: 141M shares
Disclosed Ownership: 6.64M shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 21:02:25 UTC
Date of event: 31 Mar 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Redmile Group, LLC	4.7%	6.64M	0	6.64M	/s/ Jeremy C. Green	Managing Member
Jeremy C. Green	4.7%	6.64M	0	6.64M	/s/ Jeremy C. Green	Jeremy C. Green